Asaph Kupferman is Co-Founder of Floracene, a Y Combinator-backed healthcare technology startup helping independent surgery centers identify the best-priced, clinically equivalent implants for every procedure.

Asaph studied Bioengineering at the University of Pennsylvania, minoring in Mechanical Engineering, Mathematics, and Engineering Entrepreneurship, before building deep expertise in US healthcare operations.

Asaph has spent four years in the plumbing of US healthcare, spanning claims, eligibility, and payor contracting, giving him rare operational depth across the full revenue cycle.

Asaph was an early PM at Garner and worked on the hospitals team at Palantir Technologies, where he met his co-founder Jonah and developed a firsthand understanding of healthcare system inefficiencies.

Floracene targets the $7B annual US surgery center implant market, where 20 to 30% of spend is recoverable by switching to clinically equivalent devices, directly protecting case margins for independent physicians.